论文部分内容阅读
按Vaughan、Williams分类,心律平属Ic类抗心律失常新药。心律平对室性心律失常疗效显著,总有效率83％以上。对室上性心律失常亦有不同程度的疗效。但其疗效与临床上哪些因素有相关性,鲜见报道。本文就1988年元月至1990年3月,因心律失常经心律平治疗的70例住院患者最初临床资料回顾性分析,探讨影响心律平疗效的临床因素。临床资料一、资料来源 1.心律失常均经ECG证实。口服国产心律平片剂治疗,每日剂量在300～800mg之间。 2.心律平疗效判断,是根据服药后ECG,
According to Vaughan, Williams classification, cardiomorphine class Ic anti-arrhythmic drugs. Cardioversion of ventricular arrhythmia significant effect, the total effective rate of 83% or more. Supraventricular arrhythmias have varying degrees of efficacy. However, its efficacy and clinical factors that have little relevance reported. This article retrospectively analyzed the initial clinical data of 70 hospitalized patients who were treated by arrhythmia and rhythm of arrhythmia from January 1988 to March 1990, and discussed the clinical factors influencing the efficacy of heart rhythm. Clinical data First, sources 1. Arrhythmias have been confirmed by ECG. Oral domestic cardiomorphic tablet treatment, the daily dose of 300 ~ 800mg between. 2. Cardiogram efficacy judgment, is based on the medication ECG,